Projects per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Breast Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Breast Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Paclitaxel
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Recurrence
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Single Nucleotide Polymorphism
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1999 2020
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC)
9/15/12 → 5/31/20
Project: Research project
Triple Negative Breast Neoplasms
Breast Neoplasms
Neoplasms
Histone Deacetylase Inhibitors
Estrogen Receptors
Modifying The Risk For Developing Triple Negative Breast Cancer (Tnbc)
National Institutes of Health (NIH)
9/15/12 → 5/31/18
Project: Research project
Triple Negative Breast Neoplasms
Breast Neoplasms
Neoplasms
Histone Deacetylase Inhibitors
Estrogen Receptors
Vinca Alkaloids
Doxorubicin
Breast Neoplasms
Pharmaceutical Preparations
Taxoids
Research Output 1992 2019
5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost
Goyal, S., Moore, D. F., Toppmeyer, D. & Haffty, B. G., Oct 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 2, p. 267-274 8 p.Research output: Contribution to journal › Article
acceleration (physics)
breast
radiation therapy
Breast
Radiotherapy
Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
Toppmeyer, D. & Haffty, B. G., Oct 1 2019, In : Frontiers in Oncology. 9, 970.Research output: Contribution to journal › Article
Open Access
Radiotherapy
Breast Neoplasms
Stroke Volume
Cardiotoxicity
Trastuzumab
3
Citations
(Scopus)
A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
Toppmeyer, D., Mar 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 738-745 8 p.Research output: Contribution to journal › Article
Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms
Press/Media
A Helping Hand from a Compassionate Team at Rutgers Cancer Institute of New Jersey
3/5/18
2 items of Media coverage
Press/Media: Press / Media
Fighting disease with precision at Rutgers Cancer Institute of New Jersey
Hossein Khiabanian, Shridar Ganesan & Kim Hirshfield
2/26/18
3 items of Media coverage
Press/Media: Press / Media
Using 'LOHGIC' to Assess Inherited Cancer Mutations
Hossein Khiabanian, Shridar Ganesan & Kim Hirshfield
1/23/18
1 item of Media coverage
Press/Media: Press / Media